Market Access Solutions (MKTXS)
Market Access Solutions (MKTXS) is a private US consultancy founded in 2005, based in Raritan, NJ, with 11-50 employees, specializing in pharmaceutical market access strategy and Health Economics & Outcomes Research (HEOR) advisory services for drug sponsors.
- Company typePrivate
- Founded2005
- HeadquartersRaritan, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Market Access Solutions (MKTXS) does
Market Access Solutions (MKTXS) is a privately held consulting firm headquartered in Raritan, New Jersey, that operates in the pharmaceutical market access and Health Economics & Outcomes Research (HEOR) domain. According to firmographic data, the company was founded in 2005 and maintains a small professional services workforce of 11-50 employees. The firm's functional role is to support pharmaceutical and biotechnology manufacturers in navigating payer requirements, reimbursement strategy, and the generation of health economic evidence — a highly specialized advisory niche that typically serves drug sponsors preparing for product launch, label expansion, or payer negotiations.
The company's offerings, technology stack, and go-to-market mechanics cannot be verified from the available source material. The firm's website (mktxs.com) returned only a verification/loading placeholder with no substantive content, and no product catalog, pricing model, named client logos, or technology architecture was disclosed in the aggregated data. Revenue model details, customer segment mix, partnership ecosystems, and geographic coverage beyond the Raritan, NJ headquarters are likewise unspecified. As a small, long-tenured consultancy in a specialized discipline, MKTXS likely operates on a project-based or retainer professional services model with senior-staff-led engagements, but this is inferred from industry norms rather than confirmed by source data.
For an investment audience, the key data gaps are material: no revenue figures, no funding history, no named customers, no management team visibility, and no verifiable product or technology differentiators were available. The 19-year operating history and HEOR specialization provide baseline signals of durability in a niche, but the absence of observable growth signals, AI capability, or scale evidence limits the ability to assess competitive positioning or expansion trajectory.
Market Access Solutions (MKTXS) firmographics
Firmographics- Name
- Market Access Solutions (MKTXS)
- Website
- https://mktxs.com
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- Market Access Solutions (MKTXS) is a private US consultancy founded in 2005, based in Raritan, NJ, with 11-50 employees, specializing in pharmaceutical market access strategy and Health Economics & Outcomes Research (HEOR) advisory services for drug sponsors.
- Ownership category
- akta.pro rank
Market Access Solutions (MKTXS) industry classification
Industry- Product category
- HEOR and Market Access Consulting
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO)
- akta.pro secondary industry
- DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)
Keywords
Where Market Access Solutions (MKTXS) is headquartered
LocationHeadquarters
- HQ city
- Raritan
- HQ country
- United States
- HQ region
- North America
Markets served
Market Access Solutions (MKTXS) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Market Access Solutions (MKTXS) product offering
Product offeringCore offering
Market Access Solutions (MKTXS) is a consulting firm that provides market access and Health Economics & Outcomes Research (HEOR) services. Based on its self-described positioning, it supports clients in generating evidence and strategies needed for payer access, reimbursement, and value demonstration of healthcare products.
Differentiator
Problem solved
Functional benefit
Companies that use Market Access Solutions (MKTXS)
Customer profileIdeal customer profiles1 record
Market Access Solutions (MKTXS) technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Market Access Solutions (MKTXS) competitors and assessment
Company assessmentDirect peers
- Evidera: A leading HEOR and market access consultancy (now part of Thermo Fisher/PPD) offering evidence synthesis, real-world evidence, and reimbursement support — directly comparable in service mix and target client base to MKTXS.
- PRECISIONheor (Precision Medicine Group): Specialist HEOR and market access consultancy serving biopharma with economic modeling, evidence generation, and value communications — a direct competitor to MKTXS for mid-cap pharma engagements.
- Putnam Associates: Strategy consulting firm focused on biopharma commercial strategy, market access, and pricing — competes with MKTXS for payer strategy and launch-readiness mandates.
Broad incumbents
- IQVIA: Global CRO and analytics leader with a substantial HEOR, real-world evidence, and market access practice; competes with MKTXS at the enterprise end of the market.
- ICON plc: Large CRO with a market access and HEOR advisory practice through PRA Health Sciences and other acquired units; competes with MKTXS for integrated evidence-generation work.
- Syneos Health: Biopharma solutions organization offering commercial, market access, and HEOR consulting as part of its broader clinical-to-commercial platform — a larger-scale alternative for pharma clients.
- Charles River Associates (CRA Life Sciences): Global consulting firm with a Life Sciences practice advising biopharma on pricing, market access, and commercial strategy — overlaps with MKTXS's payer and pricing work.
Emerging players
- Lumanity: HEOR- and market-access-focused consultancy formed via roll-ups of PHAR and other agencies; competes with MKTXS on payer evidence and value strategy engagements.
- Genesis Research: Specialist real-world evidence and HEOR consultancy serving biotech and pharma; a comparable mid-sized competitor to MKTXS in evidence-generation services.
- Axtria: Data analytics and commercial services firm with a market access practice focused on patient access, payer analytics, and pricing — competes with MKTXS in data-driven access work.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks5 records
Key highlights4 records
Customer concentration
Market Access Solutions (MKTXS) social profiles
Digital presenceMarket Access Solutions (MKTXS) financial estimates
Financial estimateRevenue estimate
Valuation estimate
Market Access Solutions (MKTXS) leadership team
Management profileNumber of profiles
Market Access Solutions (MKTXS) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Market Access Solutions (MKTXS) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Market Access Solutions (MKTXS)
What does Market Access Solutions (MKTXS) do?
Market Access Solutions (MKTXS) is a consulting firm that provides market access and Health Economics & Outcomes Research (HEOR) services. Based on its self-described positioning, it supports clients in generating evidence and strategies needed for payer access, reimbursement, and value demonstration of healthcare products.
When was Market Access Solutions (MKTXS) founded?
Market Access Solutions (MKTXS) was founded in 2005. It employs 11 to 50 people.
Where is Market Access Solutions (MKTXS) based?
Market Access Solutions (MKTXS) is headquartered in Raritan, United States, in the North America region.
Who are Market Access Solutions (MKTXS)'s main competitors?
Direct peers on record are Evidera, PRECISIONheor (Precision Medicine Group) and Putnam Associates. Broad incumbents are IQVIA, ICON plc, Syneos Health and Charles River Associates (CRA Life Sciences). Emerging players are Lumanity, Genesis Research and Axtria.
Does Market Access Solutions (MKTXS) have an API?
No public API is recorded for Market Access Solutions (MKTXS).
What industry is Market Access Solutions (MKTXS) in?
Market Access Solutions (MKTXS)'s product category is HEOR and Market Access Consulting. Its primary akta.pro industry code is HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 54161 and its SIC code is 8000.